Singapore, Singapore

ESTRO meets Asia 2026

Session

Friday
August 28
16:30 - 17:30
Peridot 204-206
CNS, paediatric and metastasis-directed SBRT
Ekkasit Tharavichitkul, Thailand;
Nicolaus Andratschke, Switzerland
Proffered Papers
Clinical Practice
16:30 - 17:30
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised phase 3 trial
Frank Giordano, Germany
-30
16:30 - 17:30
Incidence and Severity of Acute Hematologic Toxicities in Pediatric patients receiving either Vertebral-Body-Sparing (VBS) or Whole-Vertebral Body (WVB) Craniospinal Irradiation (CSI) at a Tertiary Government Hospital in the Philippines
JOSEPH CAUSAPIN, Philippines
-244
16:30 - 17:30
Oligometastatic Stereotactic Body Radiotherapy and its role in delaying systemic treatment
Christopher Wei En Chan,
-120
16:30 - 17:30
Endpoint Selection, Surrogacy, and Reporting Quality in Randomized Trials of Metastasis-Directed Therapy for Oligometastatic Disease
Syadwa Abdul Shukor, Malaysia
-351
16:30 - 17:30
Clinical Outcomes and Dosimetric Predictors of Vestibular Schwannoma Treated with Stereotactic Radiotherapy: A Southeast Asian Single-Institution Experience
Nur Hidayah Habil, Malaysia
-414
16:30 - 17:30
Intra-Tumoural Manganese Is Associated With Radioresistance and Survival in Glioblastoma (AO 02.25)
Gerald Fogarty, Australia
-169